MMP7 and ovarian carcinoma: Specifically, upregulation of MMP7 can be triggered by the interaction between the carboxy-terminal portion of the MUC16/CA125 protein expressed in ovarian cancer cells and mesothelin present on mesothelial cells, leading to an increase in invasive tumor properties and peritoneal carcinomatosis [31,32,33].